Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review

• Published in: Transplant infectious disease Vol. 23; no. 6; pp. e13726 - n/a
• Main Authors: Kitahara, Mari, Hiroshima, Yuki, Norose, Kazumi, Hikosaka, Kenji, Kazumoto, Hiroko, Uematsu, Nozomu, Shishido, Tsutomu, Kaiume, Hiroko, Sato, Keijiro, Ueki, Toshimitsu, Sumi, Masahiko, Watanabe, Masahide, Kobayashi, Hikaru
• Format: Journal Article
• Language: English
• Published: Denmark Wiley Subscription Services, Inc 01.12.2021
• Subjects: Antibiotics; anti‐Toxoplasma gondii‐specific IgG antibody; Autografts; autologous hematopoietic stem cell transplantation; Fatalities; Hematopoietic Stem Cell Transplantation - adverse effects; Hematopoietic stem cells; Humans; Immunocompromised hosts; Immunoglobulin G; Incidence; infection; Literature reviews; Patients; Prophylaxis; Protozoa; Retrospective Studies; Serological tests; Stem cell transplantation; Stem cells; Sulfamethoxazole; Toxoplasma; Toxoplasmosis; Toxoplasmosis - epidemiology; Transplantation; Transplantation, Autologous - adverse effects; Trimethoprim; autologous hematopoietic stem cell transplantation; anti-Toxoplasma gondii-specific IgG antibody; infection; toxoplasmosis; incidence

Background Toxoplasmosis is a rare but life‐threatening infection occurring in immunocompromised hosts, including allogeneic hematopoietic stem cell transplantation (allo‐HSCT) recipients. However, thus far, the clinical features and incidence of toxoplasmosis in autologous HSCT (auto‐HSCT) recipien...